SCHEMBL29411583

SCHEMBL29411583

O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccon1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ MAPT P10636 1/20 0.62
▸ TSHR P16473 1/20 0.62
▸ MAPKAPK2 P49137 1/20 0.62
▸ KMT2A Q03164 1/20 0.62
▸ HCAR2 Q8TDS4 1/20 0.51
▸ GAA P10253 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ RAB9A P51151 3/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.44
▸ NPC1 O15118 3/20 0.43
▸ CASP1 P29466 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NPY5R Q15761 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045123 1.00 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL21045420 0.82 ALDH1A1 (0.69) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL29411509 0.82 ALDH1A1 (0.69) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL21235033 0.80 ALDH1A1 (0.65) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL24967599 0.79 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL21227017 0.78 TSHR (0.77) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL30920079 0.78 TSHR (0.77) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL29411562 0.77 SMN1; SMN2 (0.71) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL21045264 0.77 SMN1; SMN2 (0.71) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT
SCHEMBL169905 0.77 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1MEN1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 — — US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 — — US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885ALDH1A1 3048/4885MEN1 955/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885ALDH1A1 3048/4885MEN1 955/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885ALDH1A1 3048/4885MEN1 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback